CA Stock MarketDetailed Quotes
APC.H Advanced Proteome Therapeutics Corp
- 0.005
- 0.0000.00%
15min DelayTrading Apr 11 09:30 ET
205.64KMarket Cap-61P/E (TTM)
0.000High0.000Low0Volume0.000Open0.005Pre Close0.00Turnover0.00552wk High0.00%Turnover Ratio41.13MShares0.00552wk Low-0.081EPS TTM185.75KFloat Cap0.030Historical High0.38P/E (Static)37.15MShs Float0.005Historical Low0.013EPS LYR0.00%Amplitude--Dividend TTM-5.00P/B1Lot Size--Div YieldTTM
Advanced Proteome Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | (Q3)Apr 30, 2022 | (Q2)Jan 31, 2022 | (Q1)Oct 31, 2021 | (FY)Jul 31, 2021 | (Q4)Jul 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -171.13%-696.67K | -12.32%-140.54K | -78.63%-232.27K | -27.22%-693.58K | -55.24%-223.08K | 673.88%979.41K | 6.34%-125.12K | -33.72%-130.03K | -16.75%-545.2K | -65.54%-143.7K |
| Net income from continuing operations | -392.91%-2.09M | -156.98%-332.79K | -140.41%-258.52K | 131.11%597.48K | -186.68%-117.2K | 142.16%714.69K | 13,960.81%584.09K | 275.47%639.78K | -254.63%-1.92M | 159.64%135.22K |
| Operating gains losses | 42,651.17%1.37M | 104.44%37.78K | 95.80%-35.58K | -234.55%-1.6M | 49.81%-150.13K | -99.78%3.2K | -279.99%-849.98K | -459.34%-846.25K | 2,065.03%1.19M | -819.99%-299.12K |
| Depreciation and amortization | -27.43%2.52K | 6.48%1.23K | 0.52%1.17K | 60.12%4.64K | -2.85%1.16K | 512.32%3.48K | 103.87%1.16K | 104.59%1.16K | -10.70%2.9K | 47.10%1.19K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 371.06%132.43K | --0 |
| Other non cashItems | 100.90%12.85K | 279.39%32.55K | -202.96%-7.65K | ---- | ---- | -3,416.96%-1.43M | -16.62%8.58K | 9.03%7.43K | 20.21%40.44K | -310.59%-19.77K |
| Change In working capital | -100.23%-540 | 7.37%140.7K | -28.79%48.32K | 2,307.56%301.14K | 62.86%63.15K | 550.34%237.99K | 6,190.88%131.04K | 177.03%67.86K | -82.11%12.51K | -53.74%38.78K |
| -Change in receivables | 214.53%8.4K | ---- | ---- | ---- | ---- | ---7.33K | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | ---- | -36.09%4.83K | 237.53%2.04K | 35.33%-6.52K | 113.48%809 | ---- | 271.52%7.56K | -112.30%-1.48K | -171.44%-10.09K | 2.64%-6K |
| -Change in payables and accrued expense | -103.64%-8.94K | 10.04%135.87K | -33.26%46.28K | 1,261.74%307.66K | 39.23%62.34K | 555.38%245.32K | 1,801.66%123.48K | 175.24%69.34K | -59.51%22.59K | -50.24%44.78K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -51.28%-711.78K | 3.66%-120.54K | -94.01%-252.27K | -27.22%-693.58K | -55.24%-223.08K | -175.68%-470.5K | 6.35%-125.12K | -33.72%-130.03K | -16.75%-545.2K | -65.56%-143.7K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 823.01%99.68K | -3,579,600.00%-35.8K | 0 | 72.35%-13.79K | 100.00%-1 | -13.79K | 1 | -13.79K | -49.86K | -49.86K |
| Net PPE purchase and sale | 95.10%-675 | -67,600.00%-675 | --0 | -702.09%-13.79K | 99.94%-1 | ---13.79K | --1 | ---13.79K | ---1.72K | ---1.72K |
| Net investment purchase and sale | --214.75K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---313.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---48.14K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -623.01%-99.68K | -3,579,600.00%-35.8K | --0 | 72.35%-13.79K | 100.00%-1 | ---13.79K | --1 | ---13.79K | ---49.86K | ---49.86K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -74.88%106.38K | -69.65%429.44K | -88.54%5.91K | -62.23%423.52K | 319.35%1.41M | 121.71%51.58K | ||||
| Net issuance payments of debt | -66.68%90.98K | ---- | ---- | --0 | -1,535.86%-273.09K | 1,032.26%273.09K | ---- | ---- | -44.57%48.14K | 128.90%19.02K |
| Net common stock issuance | -89.77%15.4K | ---- | ---- | -88.99%150.44K | --0 | -86.92%150.44K | ---- | ---- | 445.49%1.37M | -87.00%32.57K |
| Net other financing activities | ---- | ---- | ---- | --279K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -74.88%106.38K | ---- | ---- | -69.65%429.44K | -88.54%5.91K | -62.23%423.52K | ---- | ---- | 319.35%1.41M | 121.71%51.58K |
| Net cash flow | ||||||||||
| Beginning cash position | -33.80%544.43K | -54.00%312.16K | -33.80%544.43K | 33,797.77%822.36K | -21.02%761.6K | 5,862.59%822.36K | 19,420.86%678.55K | 28,694.12%822.36K | -98.16%2.43K | 1,362.10%964.34K |
| Current changes in cash | -732.32%-505.72K | -180.03%-75.54K | -61.50%-232.27K | -133.90%-277.93K | -52.96%-217.17K | -106.26%-60.76K | 1,120.06%94.4K | -23,295.97%-143.82K | 732.90%819.93K | -123.49%-141.98K |
| End cash Position | -94.92%38.71K | -69.39%236.62K | -54.00%312.16K | -33.80%544.43K | -33.80%544.43K | -21.02%761.6K | 5,504.27%772.94K | 19,420.86%678.55K | 33,797.77%822.36K | 33,797.77%822.36K |
| Free cash from | -47.12%-712.46K | 3.12%-121.21K | -75.41%-252.27K | -29.34%-707.37K | -53.40%-223.08K | -183.76%-484.28K | 6.35%-125.12K | -47.90%-143.82K | -17.12%-546.92K | -67.54%-145.42K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data